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Terminal differentiation ofmultipotent stem cells is achieved
through a coordinated cascade of activated transcription factors
and epigenetic modifications that drive gene transcription
responsible for unique cell fate. Within the mesenchymal line-
age, factors such as RUNX2 and PPAR are indispensable for
osteogenesis and adipogenesis, respectively. We therefore
investigated genomic binding of transcription factors and
accompanying epigenetic modifications that occur during
osteogenic and adipogenic differentiation of mouse bone mar-
row-derived mesenchymal stem cells (MSCs). As assessed by
ChIP-sequencing and RNA-sequencing analyses, we found that
genes vital for osteogenic identity were linked to RUNX2,
C/EBP, retinoid X receptor, and vitamin D receptor binding
sites, whereas adipocyte differentiation favored PPAR, reti-
noid X receptor, C/EBP, and C/EBP binding sites. Epigenetic
marks were clear predictors of active differentiation loci as well
as enhancer activities and selective gene expression. Thesemar-
row-derived MSCs displayed an epigenetic pattern that sug-
gested a default preference for the osteogenic pathway; however,
these patterns were rapidly altered near the Adipoq, Cidec,
Fabp4, Lipe, Plin1, Pparg, and Cebpa genes during adipogenic
differentiation. Surprisingly, we found that these cells also
exhibited an epigenetic plasticity that enabled them to trans-
differentiate from adipocytes to osteoblasts (and vice versa)
after commitment, as assessed by staining, gene expression, and
ChIP-quantitative PCR analysis. The osteogenic default path-
waymaybe subvertedduringpathological conditions, leading to
skeletal fragility and increased marrow adiposity during aging,
estrogendeficiency, and skeletal unloading. Taken together, our
data provide an increasedmechanistic understanding of the epi-
genetic programs necessary for multipotent differentiation of
MSCs thatmayprovebeneficial in thedevelopment of therapeu-
tic strategies.
The mesenchymal stem cell (MSC)2 is a multipotential unit
with the ability to differentiate along osteogenic, adipogenic,
chondrogenic, myogenic, and neurogenic pathways (1). A com-
mon source of MSCs is derived from bone marrow. In addition
to bone marrow, however, MSCs can also be isolated from adi-
pogenic tissue sources (aMSC or ASC), umbilical cord tissue,
pancreas, andmost other vascularized tissues (1). Regardless of
the source, these cells retain their ability to differentiate into a
number of common lineages when appropriately stimulated,
displaying cell markers such as CD29, CD44, CD70, CD73,
CD90, CD105, and Stro-1, while lacking markers for early
hematopoietic lineages (CD34 and others) (2, 3). Although the
markers for identification of a “true” MSC remain somewhat
controversial, multipotential differentiation morphology
remains the hallmark of theMSC. These phenotypes are driven
by distinct and essential sets of cell signaling pathways and their
respective target transcription factors. Adipogenic differentia-
tion relies on the expression of peroxisome proliferator-acti-
vated receptor  (PPAR), and agonists of the PPAR pathway
promote the formation of adipocytes at the expense of osteo-
blasts (4, 5). Osteogenic differentiation, on the other hand, can-
not proceed without expression of Runt-related transcription
factor 2 (RUNX2) (6, 7) and its downstream effects on osterix
(OSX, Sp7) expression. Wnt and Hedgehog signaling pathways
favor the osteogenic versus the adipogenic lineage (8, 9). Like-
wise, bone morphogenic proteins and TGF direct MSCs
toward both osteogenic and chondrogenic phenotypes (10).
Interleukins and STAT signaling uniquely promote specific
chondrogenic differentiation (11). In addition to chemical sig-
nals, MSCs are able to respond to cues from physical interac-
tions with intranuclear actin to up-regulate RUNX2 as well as
to repress adipogenesis through down-regulation of C/EBP
and PPAR in response to mechanical loading that favors bone
(12–14). In all, theMSC is a versatile cell capable of responding
to various signals for varied terminal differentiation programs.
One of themajor transcription factors active in preosteogen-
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ary activator ofMSCs. VDR is able to regulate the expression of
genes that are vital to osteoblastic identity in early osteoblastic
cells as well as in MSCs through coordination with the actions
of RUNX2 and C/EBP (15, 16). The VDR has a pervasive
genomic footprint in preosteoblastic cells that is reduced as
these cells undergo further osteoblastic differentiation, but
VDR is still an active regulator of transcription in both differ-
entiation states (15). Likewise, recent efforts have beenmade to
establish a role for the VDR in the adipocyte, where, as in the
osteoblast, VDR has a somewhat conflicted role throughout
differentiation. Global VDR knock-out in mice results in adi-
pocyte atrophy, and mice with the VDR ablated specifically in
adipose tissue show increased mammary epithelial density (17,
18). The active metabolite of vitamin D, 1,25(OH)2D3, has been
shown to prevent adipocyte differentiation in vitro and simul-
taneously up-regulate cytokine and leptin activity in fat tissue
(19, 20). Despite the specifics of these activities, VDR is present
in cells of all mesenchymally derived lineages and remains an
important transcription factor in vivo for both osteoblasts and
adipocytes.
The regulatory activities of these transcription factors are
accompanied (or preceded) by epigenetic modifications to
either DNA or to histone protein tails to allow additional tran-
scription factor access to genes vital for lineage determination.
The epigenetic marks in osteoblastic cells (15, 16, 21) and in
adipocyte cell culture models (22) have revealed distinct pat-
terns for gene expression in terminally differentiated cell types.
Previous research has determined that the histone-modifying
enzymes responsible for many of these patterns, including
KDM5B, EZH2, and others, play a clear role in skeletal devel-
opment and differentiation of the MSC through modulation of
RUNX2 (23, 24). A recent study found distinct open regions of
DNase I-hypersensitive DNA in a human temperature-depen-
dent model of osteoblast differentiation that favored genes
known for the osteoblastic phenotype (25). Chromatin marks
are dynamic in nature and can shift location based upon the
stimulus received (26). In fact, the plasticity of histone and
chromatin modifications is believed to allow for memory con-
text in the brain (27), circadian rhythm (28, 29), and even the
potential for trans-differentiation fromone cell type to another,
as exemplified by smooth muscle cell transitions into macro-
phages in atherosclerosis (30). Trans-differentiation of mes-
enchymal cells can be used to create neural stem cells (31),
insulin-producing cells (32), auditory cells (33), or other thera-
peutically relevant cell lines. Their accessibility and availability
havemadeMSCs (stromal or adipose-derived) an attractive cell
type for studies in personalized regenerative medicine.
Given the diverse differentiation potential of marrow-de-
rivedMSCs as well as their dynamic nature, we sought to inves-
tigate the transcription factor cascades as well as histone mod-
ification patterns that characterize these differentiating cells.
We differentiatedMSCs in culture for 7 or 15 days using osteo-
genic medium and 7 days using adipogenic medium. At these
time points, we performed RNA-seq analysis to establish
changes in the transcriptome and ChIP-seq analysis to investi-
gate the cistromes for a number of transcription factors
(RUNX2, C/EBP, C/EBP, PPAR, VDR, and RXR) as well
as several epigenetic marks (H3K9ac, H4K5ac, H3K4me1,
H3K4me3, and H3K36me3) that are associated with these
transitions. We found that chromatin state profiles for the
undifferentiated MSC closely resembled those of osteogenic
cells differentiated for 7 or 15 days, indicating a potentially pre-
determined epigenetic pathway for these cells. These chro-
matin state profiles were dramatically altered, however, follow-
ing adipogenic differentiation for 7 days, especially near genes
vital for adipogenic function. These profiles accurately pre-
dicted the transition and gene output activity at the locus in
which they resided. Finally, we found that despite numerous
genomic, chromatin, and gene expression changes, MSCs were
able to trans-differentiate from an adipogenic to an osteogenic
lineage and vice versa. These two cell types displayed the appro-
priate cell morphology, transcriptomic, and genomic changes
of the emerging trans-differentiated phenotype and demon-
strated a plasticity in the histone modifications that allowed
these transitions to occur in vitro. These observations provide a
potential mechanism during pathological conditions that lead
to skeletal fragility and increased marrow adiposity as in aging,
estrogen deficiency, and in skeletal unloading. These expres-
sion patterns and profiles will be beneficial in understanding
the mechanisms that underlie the cellular and genomic transi-
tions that occur during differentiation and may lead to insights
that will be required for the successful development of thera-
pies or drug discovery models in the future.
Results
Marrow-derived MSCs Differentiate into Mature Adipocytes
and Osteoblasts—Marrow-derived MSCs present an interest-
ing model of differentiation because they are capable of transi-
tioning into a wide variety of cell types, most notably osteo-
blasts, adipocytes, and chondrocytes. In the marrow space,
stromal cells differentiate into these cell types tomaintain bone
integrity and health. We chose to investigate the genetic (tran-
scription factors) and epigenetic (histone modifications) path-
ways involved in the differentiation of the MSCs to osteoblasts
and adipocytes. As outlined in Fig. 1 and detailed under “Exper-
imental Procedures,” marrow-derived cells were isolated from
C57bl/6 mice, and selected MSCs were cultured and validated
as described previously (34, 35). MSCs were then expanded for
differentiation, staining, ChIP-seq, and RNA-seq analyses.
They were then induced for 7 days in adipogenic medium
(MSC-F7) or for 7 (MSC-B7) and 15 (MSC-B15) days with
osteogenic medium. At these time points, the cells were col-
lected for staining, ChIP-seq, and RNA-seq analysis. Oil Red O
(ORO) staining was performed to examine lipid accumulation
in adipocytes, and alizarin red (AR) staining was used to detect
calcium deposition in mineralizing osteoblasts. The differenti-
ation states displayed the appropriate cell morphology and
staining as in Fig. 1.
Having established the anticipated morphology, we then
confirmed appropriate transcriptomic changes as well. As can
be seen in Fig. 2, differentiated MSCs were easily distinguished
as either osteoblasts (MSC-B7) or adipocytes (MSC-F7) from
their gene expression profiles. These patterns identified in
MSC, MSC-B7, MSC-B15, and MSC-F7 cells are displayed as
heat maps from a hierarchical clustering analysis (using Euclid-
ean distance) of the top 200 up-regulated (top) and down-reg-
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ulated (bottom) genes contrasting MSC-B7 versus MSC (Fig.
2A) and MSC-F7 versus MSC (Fig. 2B). A large contingent of
the genes up-regulated in MSC-B7 cells was also up-regulated
inMSC-B15 cells, as can be observed by the gene clusters. This
relationship is better visualized through the Venn diagrams
documented in Fig. 2C. Here, genes that were up-regulated
2-fold within a 95% confidence interval (moderated t test)
versus MSCs are shown on the left. A total of 373 genes were
up-regulated in MSC-B7 cells (versus MSCs), 658 genes
were up-regulated in MSC-B15 (versusMSC), and 1,312 genes
were up-regulated inMSC-F7 cells (versusMSCs). Similarly, an
analysis of the down-regulated genes revealed that there were
many more genes suppressed in each condition: MSC-B7 with
9,152,MSC-B15with 8,005, andMSC-F7with 12,711 genes. As
expected, both the up- and down-regulated genes of MSC-B7
andMSC-B15 cells displayedmore closely related gene expres-
sion patterns than those with MSC-F7 cells; however, many
genes were unique to both the MSC-B7 and MSC-B15 differ-
entiation states.
We then examined these gene networks through the Gene-
MANIA (Gene Multiple Association Network Integration
Algorithm) pathway and literature analysis tool (36). As shown
in Fig. 2D, the top osteogenic genes shared in common with
both the MSC-B7 and MSC-B15 cells are displayed. The genes
within the black circles are those explored in GeneMANIA.
These were computed to exhibit connections between each
other as well as with genes predicted to be within a gene regu-
latory network (gray circles). We found that these highly regu-
lated genes were tightly correlated with not only the algorithm
prediction (orange lines) but also genes known to be co-ex-
pressed (purple) and/or co-localized (blue). Furthermore, this
gene network can be interrogated by gene ontology (GO) anal-
ysis through the DAVID (Database for Annotation, Visualiza-
tion, and IntegratedDiscovery) functional analysis tool (37, 38).
The gene network associated with osteogenic differentiation
was highly enriched for GO terms related to skeletal formation,
ossification, and extracellular structure organization (Fig. 2E).
In fact, osteocytic genes shared with MSC-B7 and MSC-B15
cells were further increased in the MSC-B15 cells, suggesting
that by day 15, theMSCswere either progressing toward or had
become osteocytes, as recently suggested (39). Interestingly,
gremlin-1 (Grem1) expression was identified following osteo-
blast differentiation;Grem1-positiveMSCs are hypothesized to
be unable to differentiate into adipocytes (40). Similarly, genes
up-regulated in MSC-F7 cells versus MSCs were also interro-
gated using the GeneMANIA pathway analysis (Fig. 2F) as well
as DAVID functional analysis tools (Fig. 2G). The interactions
within the adipogenic network of genes were tighter than those
within MSC-B7 and MSC-B15 cells. These genes were highly
enriched in GO categories involved in adipogenesis. Thus, the
MSC-F7 transition was the more extreme differentiation pro-
cess, although we suspect that associated transcriptomic
changes in MSCs of fat origin could well be different. Taken
together, the transcriptome analyses indicate that MSCs
express the necessary gene profiles for osteoblasts, osteocytes,
and adipocytes and that larger transcriptomic changes are
observed duringmarrow-derivedMSC differentiation into adi-
pocytes than into bone cells.
MSC Differentiation Is Driven by Specific and Unique Tran-
scription Factor Complexes—Transcriptomic changes (gene
expression) are a direct consequence of genomic regulation.
Transcription factors that respond to cellular stimuli are able to
bind to the genome and activate the transcription of lineage- or
stimuli-dependent genes. Here, we sought to investigate
lineage-dependent transcription factors and to define a role for
a secondary effector in hormone-dependent VDR activities.
Therefore, MSCs were differentiated into MSC-B7, MSC-B15,
or MSC-F7 cells and then treated with either vehicle (ethanol)
or 100 nM 1,25(OH)2D3 for 3 h, as indicated. ChIP-seq analysis
was performed at each of these differentiation time points for
VDR, RXR, RUNX2, C/EBP, C/EBP, and PPAR in MSC,
MSC-B7, and MSC-F7 cells. Table 1 provides direct genomic
binding quantitation for these factors as overlapping or unique
ChIP-seq transcription factor DNA binding peaks after ChIP-
seq interrogation (bioinformatically determined genomic loca-
tions where protein-DNA binding was enriched200–300 bp
in length) between each differentiation state. TabularVenn dia-
grams depict the total number of peaks found in each data set
for each antibody. For example, there were 1,752 total peaks for
VDR in the unstimulated (vehicle) condition in MSCs. This
numberwas dramatically reduced to only 245 peaks inMSC-B7
cells. 241 sites were found to overlap in each condition, leaving
1,511 peaks exclusively in MSCs and only four peaks unique to
MSC-B7 cells. This pattern was similar for the remaining tran-
scription factors. C/EBP and PPAR were not investigated in
MSC-B15 cells.
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FIGURE 1. Experimental overview. Primary bonemarrow cells were isolated
and cultured to preserve the MSCs. Following the isolation, the cells were
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Recently, we found that VDR/RXR, RUNX2, and C/EBP
were highly correlated to sites near genes that were important
for the differentiation of preosteoblastic MC3T3-E1 cells into
more mature mineralizing osteoblasts and described this as an
osteoblast enhancer complex (15, 16). In MSCs, we found a
similar relationship.As can be seen in Fig. 3A, peak locations for
VDR/RXR (9,599 1,25(OH)2D3-stimulated peaks) overlapped
those with RUNX2 (33,266 peaks) and C/EBP (46,232 peaks).
Indeed, we found that these three transcription factors have
4,567 commonbinding locations throughout theMSCgenome.
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After differentiation, whereas the cistromes for each of these
factors were quantitatively lowered, especially in the case of the
VDR, there were 177 genomic locations in which VDR/RXR,
RUNX2, and C/EBPwere found to overlap. In fact, the 15,000
RUNX2 and C/EBP binding sites that overlapped in MSCs
were reduced to 6,000 upon differentiation (MSC-B7).
Similarly, there was a high degree of overlap in the factors
responsible for adipogenic differentiation. In Fig. 3B, whereas
C/EBP, C/EBP, and PPAR were found to overlap at 11,542
locations in the undifferentiated MSC, this number was signif-
icantly reduced to 6,494 regions in MSC-F7 cells, led by strong
decreases in C/EBP binding activity post-differentiation
(from 46,232 to 22,986). As Fig. 3B and Table 1 illustrate,
although the total number of C/EBP peaks remained constant
near 40,000 in both the MSCs and MSC-F7 cells, the locations
of these sites changed dramatically, resulting in only 22,181
overlapping peaks with nearly 20,000 peaks unique to both
MSCs and MSC-F7 cells. The same observation was made for
PPAR. However, in both cases, the primary drivers of adipo-
genesis, C/EBP, and PPAR remain highly correlated (41).
Finally, because genomic programs remain present in MSCs to
drive subsequent multilineage differentiation, the overlap
between VDR/RXR, RUNX2, C/EBP, and PPAR was exam-
ined. These factors assembled collectively at 4,173 sites across
FIGURE 2. Marrow-derived MSCs differentiate into mature adipocytes and osteoblasts. MSCs were differentiated with osteogenic medium for 7
days (MSC-B7) and 15 days (MSC-B15) or with adipogenic medium for 7 days (MSC-F7) and compared with MSC day 0 cells (MSC). The resulting RNA was
reverse-transcribed and analyzed by sequencing. The top 200 genes that were up- and down-regulated were clustered using hierarchical clustering
followed by Euclidean distancemetric and displayed in a heatmap for those osteogenic genes (MSC-B7) (A) and adipogenic genes (MSC-F7) (B) on a log2
scale as indicated. C, gene expressionwas compared for each differentiation state versusMSC (day 0) and displayed as -fold change that was greater than
both 2-fold and 95% moderated t test confidence interval (CI). Overlapping genes are represented in the Venn diagram (up-regulated genes, left, red;
down-regulated genes, right, blue) with total regulated genes listed under the differentiation state. D, gene association was investigated through
GeneMANIA interactions, where input genes (black circles) were predicted to interact with each other as well as proposed networked genes (gray circles)
through algorithm prediction (yellow lines), co-expression (pink lines), co-localization (blue lines), or shared protein domains (green) from the literature.
Higher correlation results in a denser network with the gene connection lines being shorter. E, gene association was also interrogated for osteogenic
genes through DAVID functional analysis tools, which led to the enriched GO categories as listed with correlated p values (right). The top GO terms are
listed for the up-regulated (left) and down-regulated genes (right). F, genes up-regulated by adipogenic differentiation were interrogated by Gene-
MANIA as in D and G and DAVID GO term correlation as in E.
TABLE 1
Venn diagramdatawith differentiation state (left) with total peaks indicated in parentheses versus the indicated differentiation state (right) for
each specific antibody or treatment (VDR and RXR have vehicle and 1,25(OH)2D3 conditions; the remainder are vehicle-treated cells)
Those peaks found only in the left condition are shown under “Only” on the left; those that are found in both the left and right are shown under “Overlapping”; and those
found only in the right condition shown under “Only” on the right. 1,25, 1,25(OH)2D3.
Antibody Cell (total peaks) Only Overlapping Only Cell (total peaks)
VDR vehicle MSC (1,752) 1,511 241 4 MSC-B7 (245)
MSC (1,752) 1,436 316 23 MSC-B15 (339)
MSC (1,752) 1,411 341 33 MSC-F7 (374)
MSC-B7 (245) 2 243 96 MSC-B15 (339)
MSC-B7 (245) 12 233 141 MSC-F7 (374)
MSC-B15 (339) 60 279 95 MSC-F7 (374)
VDR 1,25 MSC (10,557) 9,812 745 78 MSC-B7 (823)
MSC (10,557) 9,325 1,232 133 MSC-B15 (1,365)
MSC (10,557) 9,988 569 47 MSC-F7 (616)
MSC-B7 (823) 127 696 669 MSC-B15 (1,365)
MSC-B7 (823) 386 437 179 MSC-F7 (616)
MSC-B15 (1,365) 901 464 152 MSC-F7 (616)
RXR vehicle MSC (26,106) 15,601 10,504 1,954 MSC-B7 (12,458)
MSC (26,106) 17,417 8,689 1,684 MSC-B15 (10,373)
MSC (26,106) 19,112 6,994 10,207 MSC-F7 (17,201)
MSC-B7 (12,458) 5,041 7,417 2,956 MSC-B15 (10,373)
MSC-B7 (12,458) 8,484 3,974 13,227 MSC-F7 (17,201)
MSC-B15 (10,373) 6,951 3,422 13,779 MSC-F7 (17,201)
RXR 1,25 MSC (30,622) 16,825 13,797 2,516 MSC-B7 (16,313)
MSC (30,622) 21,539 9,083 1,318 MSC-B15 (10,401)
MSC (30,622) 25,339 5,283 7,575 MSC-F7 (12,858)
MSC-B7 (16,313) 8,076 8,237 2,164 MSC-B15 (10,401)
MSC-B7 (16,313) 12,752 3,561 9,297 MSC-F7 (12,858)
MSC-B15 (10,401) 7,777 2,624 10,234 MSC-F7 (12,858)
RUNX2 MSC (33,266) 15,524 18,042 7,421 MSC-B7 (25,463)
MSC (33,266) 17,734 15,532 3,632 MSC-B15 (19,164)
MSC (33,266) 21,227 12,039 4,248 MSC-F7 (16,287)
MSC-B7 (25,463) 11,208 14,255 4,909 MSC-B15 (19,164)
MSC-B7 (25,463) 13,461 12,002 4,285 MSC-F7 (16,287)
MSC-B15 (19,164) 10,949 8,072 8,215 MSC-F7 (16,287)
C/EBP MSC (46,232) 28,449 17,783 1,396 MSC-B7 (19,179)
MSC (46,232) 20,546 25,666 16,326 MSC-B15 (41,992)
MSC (46,232) 30,732 15,500 7,486 MSC-F7 (22,986)
MSC-B7 (19,179) 1,241 17,938 24,054 MSC-B15 (41,992)
MSC-B7 (19,179) 8,997 10,182 12,804 MSC-F7 (22,986)
MSC-B15 (41,992) 30,549 11,443 11,543 MSC-F7 (22,986)
C/EBP MSC (42,986) 15,676 27,309 6,891 MSC-B7 (34,200)
MSC (42,986) 20,804 22,181 18,292 MSC-F7 (40,474)
MSC-B7 (34,200) 15,268 18,932 21,541 MSC-F7 (40,474)
PPAR MSC (25,701) 15,661 10,040 2,700 MSC-B7 (12,740)
MSC (25,701) 16,470 9,231 14,045 MSC-F7 (23,278)
MSC-B7 (12,740) 7,166 5,574 17,704 MSC-F7 (23,278)
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the genome, although many additional unique and subcombi-
natorial sites also exist. The overlapping peak regions for these
and perhaps other factors suggest that these sites represent
transcription factor “hot spots” for the regulation of this mes-
enchymal-derived lineage as recently proposed (41, 42).
A prime example of overlapping ChIP-seq peaks is evident at
theMmp13 and Adipoq genomic regions. In Fig. 3D, ChIP-seq
data are presented where individual data tracks are overlaid
(track hubs) for MSCs (pink), MSC-B7 (blue), MSC-B15 (yel-
low), and MSC-F7 (green) cells normalized by sequence tag
number and to input sample. ChIP-seq data tracks are pre-
sented for VDR (treated for 3 h with 100 nM 1,25(OH)2D3),
RXR, C/EBP, RUNX2, C/EBP, and PPAR antibodies. Our
recently published work on the Mmp13 gene locus defined a
distinct set of enhancers located upstream of the transcrip-
tional start site (TSS) at 10, 20, and 30 kb for VDR,
RUNX2, andC/EBP (43). These sites and factor occupancy are
identical in the MSCs, although several of these enhancers also
contain additional C/EBP and PPAR binding activities as
well. For the Mmp13 gene, however, significant increases in
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FIGURE 3.MSC differentiation is driven by specific and unique transcription factor complexes. ChIP-seq was performed with antibodies for VDR, RXR,
RUNX2, and C/EBP in MSCs (day 0) as well as MSCs differentiated with osteogenic medium (MSC-B7) (A) or C/EBP, C/EBP, and PPAR differentiated with
adipogenic medium (MSC-F7) (B). Overlapping ChIP-seq peaks are displayed in Venn diagrams. Total ChIP-seq peak numbers are indicated below each
antibody. C, intersections of VDR, RXR, RUNX2, C/EBP, and PPAR are shown by a Venn diagram with total ChIP-seq peak numbers indicated below each
antibody. D, overlaid ChIP-seq tracks are displayed for VDR, RXR, C/EBP, RUNX2, C/EBP, and PPAR in the MSC (pink), MSC-B7 (blue), MSC-B15 (yellow), and
MSC-F7 (green) cells at theMmp13 andAdipoq genomic regions. Genomic location and scale are indicated (top), andmaximumheight of tag sequence density
for eachdata track is indicatedon the y axis (top leftof each track, normalized to input and107 tags). Gene transcriptional direction is indicatedby anarrow, and
exons are shownas boxes (top). E, ChIP-seqpeaks are correlated to those genes thatwere up- or down-regulated. ChIP-seqpeak locations for VDR/RXR, RUNX2,
and C/EBP (top, 4,567 regions) or C/EBP, C/EBP, and PPAR (bottom, 11,542 regions) were converted into nearby genes using the GREAT genomic
association rules (4,452 genes and 7,869 genes, respectively). These genes were then compared with the genes that were found to be up-regulated (red) or
down-regulated (blue) byRNA-seq. The resultinggene listswere then comparedusingDAVID functional analysis tools,which led to theenrichedGOcategories
as listed with correlated p values (right).
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factor binding were not apparent for any particular cell differ-
entiation state because the Mmp13 gene is expressed and up-
regulated in each of these cell types (supplemental Table 1).
This was in stark contrast to the regulation of the Adipoq gene
and transcription factor binding activity within its locus. The
Adipoq gene is highly up-regulated in MSC-F7 cells (115-fold)
and controlled in part through the binding of C/EBP, PPAR,
and its promiscuous RXR heterodimer binding partner. These
findings are apparent in the ChIP-seq data set documented in
Fig. 3D (right). There were, however, increases in PPAR and
RXR binding near and immediately upstream of the Adipoq
TSS specifically in MSC-F7 cells, as indicated by increases in
peak amplitude (enrichment of green color). Despite these
increases inMSC-F7 cells versusMSCs (115-fold), there appear
to be low expression levels of Adipoq in MSCs and MSC-B7
cells. These residually bound transcription factors may facili-
tate basal expression.
Finally, when ChIP-seq analyses and RNA-seq gene expres-
sion data were combined, genes were enriched for osteoblast-
or adipocyte-specific pathways. In Fig. 3E, ChIP-seq peaks are
linked to nearby genes through the Genomic Regions Enrich-
ment of Annotations Tool (GREAT) (44).We used the GREAT
algorithm and the “basal plus extension” standard rule wherein
each gene is assigned to a basal regulatory domain of 5 kb
upstream and 1 kb downstream of the TSS and the gene regu-
latory domain is then extended in both directions to the nearest
gene’s basal domain by nomore than 1Mb in a single direction.
4,567 genomic locations contained overlapping peaks of VDR/
RXR, RUNX2, and C/EBP and were localized to 4,452 genes.
Thus, many genes contain multiple binding sites within their
genomic loci as determined by GREAT. The intersection of
these peak-associated genes with those that were actually reg-
ulated yields only 172 up-regulated (or 46% of the total) and
1,018 (or 11%) down-regulated genes through differentiation
(independent of any vitamin D activity). These gene groups
were then evaluated by the DAVID functional analysis tool and
displayed as enriched GO group terms (38, 45). Genes up-reg-
ulated in MSC-B7 cells were highly correlated to skeletal for-
mation, with groups such as skeletal system development, ossi-
fication, and cartilage development being enriched and
containing specific p value scores 0.05. Conversely, peaks
associated with the down-regulated genes were involved in
broad generic categories with lower enrichment scores. 11,542
peaks located at the intersection of C/EBP, C/EBP, and
PPAR were found to be associated with 7,869 genes. These
peak-associated genes were coordinated with 46% of the up-
regulated genes and only 25% of the down-regulated genes. Up-
regulated genes were associated with adipogenic processes,
such as energy creation, and down-regulated genes were found
to be involved in cell adhesion and migration. Up-regulated
genes were better correlated with the gene regions that con-
tained peaks of transcription factor binding. Although this does
not define a role for transcription factor peaks near genes that
are not regulated, many of these genes are still expressed within
the different lineages (linear RNA-seqRPKMvalue1). There-
fore, basal (not statistically inducible) expression may still
require transcription factor proximity.
Contribution to Gene Regulation by the Vitamin D Hor-
mone—VDR is widely expressed in many tissues and can be
up-regulated at both the transcriptional and post-translational
levels upon ligand binding, the latter probably through a stabi-
lization mechanism imposed by 1,25(OH)2D3 (46). The VDR is
a ligand-inducible steroid hormone receptor and may have a
mechanism of DNA binding and gene activation different from
that of factors such as RUNX2 or C/EBP (15, 16), which are
generally prebound to DNA and activated through post-trans-
lational modification. VDR appears to be restrictive for differ-
entiation (15) yet exhibits pervasive binding activity through-
out the genome. Recently, we found that the levels of VDR
decreased in differentiated osteoblasts, although lowered con-
centrations of VDR were still sufficient to activate gene tran-
scription (15). We therefore assessed these behaviors of the
VDRduring the course ofMSCdifferentiation, as can be seen in
Fig. 4. A similar number of genes were statistically up-regulated
in MSCs (173 genes) and in MSC-B7 (311 genes), MSC-B15
(218 genes), and MSC-F7 (293 genes) cells after a 24-h treat-
ment with 100 nM 1,25(OH)2D3. However, the number of genes
down-regulated by 1,25(OH)2D3 after differentiation decreased
dramatically, from 337 to 95, 56, and 99, respectively. The over-
laps of these regulated genes appear in Venn diagram form in
Fig. 4A. Surprisingly, although only 11 genes were up-regulated
(2-fold,95% confidence interval) in all three differentiation
states (Cyp24a1, Prrg4, Sema3e, Fgl2, Inmt, Gpdp5, Neu3,
Enpp3,Mdfi, Klhl33, and Grk5), only a single gene was statisti-
cally down-regulated (Ibsp). The complete gene lists can be
found in supplemental Table 1.
Similar to the observationsmade inMC3T3-E1 cells (15), the
genomic binding activity of the VDR is decreased dramatically
after differentiation. Protein levels of VDR, however, were sup-
pressed to a lesser degree in MSC-B7 and MSC-B15 cells (data
not shown) than in MC3T3-E1 cells. In Fig. 4B, the ChIP-seq
peak data for VDR binding in both vehicle (Veh)- and
1,25(OH)2D3 (1,25D3)-treated cells is summarized. VDR bind-
ing increased inMSCs from 1,752 peaks to 10,557 peaks, which
is consistent with the ligand-activated nature of VDR DNA
recruitment. Although the numbers of VDR binding sites were
not identical, much of the MSC data overlapped that seen in
MC3T3-E1 cells (vehicle, 947; 1,25(OH)2D3, 7,007) at90% of
all genomic locations (data not shown). Despite the decrease in
genomic binding of VDR in each of the differentiation states,
however, this binding remained generally ligand-dependent,
although a modest but significant VDR binding activity at
selected sites on the genome in the absence of 1,25(OH)2D3 is
present in multiple cell types and was evident in MSCs as well
(15, 47, 48). 1,408 of the 1,752 VDR peaks seen in the MSCs in
the absence of 1,25(OH)2D3 were shared with the 10,557 peaks
detected after 1,25(OH)2D3 stimulation, leaving only 344 peak
regions occupied by VDR across the genome in the absence of
ligand. Finally, the VDR DNA binding partner RXR was found
at greater than 90% of the VDR peak locations, and the remain-
ing 10% exhibited a level of RXR enrichment that was evident
but did not reach statistical significance (data not shown, avail-
able in raw ChIP-seq reads). Importantly, the most common de
novo motif found by HOMER sequence overrepresentation in
each differentiation state belonged to a canonical DR3 type
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FIGURE 4. Contribution to gene regulation by the vitamin D hormone.MSCs at day 0 (MSC), differentiated for 7 days (MSC-B7) or 15 days (MSC-B15) with
osteogenicmediumor 7 days (MSC-F7) with adipogenicmediumwere treatedwith a single dose of vehicle or 100 nM 1,25(OH)2D3 for 24 h. A, gene expression
was investigated as -fold change 1,25(OH)2D3 (1,25D3) versus vehicle (Veh) greater than both 2-fold and 95% moderated t test confidence interval (CI).
Overlapping genes are represented in the Venn diagram (up-regulated genes, left, red; down-regulated genes, right, blue) with total regulated genes listed
under thedifferentiation state.B, ChIP-seqwasperformedafter 3hof treatmentwith 100nM1,25(OH)2D3or vehicle, andpeakswere tabulated as indicated. The
table displays Venn diagram data, where differentiation state in vehicle condition (left) with total peaks indicated in parentheses is shown versus the
1,25(OH)2D3 condition (right). Those peaks found only in the vehicle condition are shown in only on the left; those that are found in both the vehicle and
1,25(OH)2D3 are shown in overlapping; and those found only in the 1,25(OH)2D3 condition are shown in only on the right. C, ChIP-seq peaks for RXR were
performed as in B, and then each 1,25(OH)2D3 condition was overlapped with the VDR in the 1,25(OH)2D3 condition. The numbers listed represent numbers
of peaks where RXR and VDR are found in the same peak genomic location for each differentiation state. D, an analysis of de novo overrepresentation of
sequences present in eachpeakwasperformedbyHOMER. The top three rankingmotif logos are listed alongwith their bestmatched transcription factor (left),
associated p value (middle), and abundance shown as a percentage (black) compared with 50,000 GC content-matched sequences (red) above each logo for
MSC (top), MSC-B7 (middle), andMSC-F7 (bottom). E, ChIP-seq peaks are correlated to those genes that were up- or down-regulated by 1,25(OH)2D3. ChIP-seq
peak locations for VDR/RXR (9,599 peaks) were converted into nearby genes using the GREAT genomic association rules (7,167 genes). These geneswere then
compared with the genes that were found to be up-regulated (red) or down-regulated (blue) by 1,25(OH)2D3 through RNA-seq. The resulting gene lists were
then comparedusingDAVID functional analysis tools,which led to theenrichedGOcategories as listedwith correlatedp values (right). OverlaidChIP-seq tracks
are displayed for VDR inMSC, MSC-B7, MSC-B15, andMSC-F7, as well as RXR inMSC, treated with vehicle (Veh, yellow) or 1,25(OH)2D3 (1,25D3, blue), where the
overlapping regions appear as green at theMdfi (F), Prrg4 (G), and Gdpd5 (H) genomic regions. Genomic location and scale are indicated (top), and maximum
height of tag sequence density for each data track is indicated on the y axis (top left of each track, normalized to input and 107 tags). Gene transcriptional
direction is indicated by an arrow, and exons are shown as boxes (top).
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VDRE (Fig. 4D). However, a further position weight matrix-
based search of these ChIP-seq peaks suggested that 92% of the
VDR peaks contained a DR3 type VDRE, as found by Geno-
matix (VDR_RXR.01 and VDR_RXR.04, core similarity 0.75,
matrix similarity optimum0.10) (49). Therefore, there is lim-
ited evidence for an abundance of alternative DNA binding
modes (homodimer, tethering, non-canonical VDRE) for the
VDR aside from the canonical VDR/RXR heterodimer.
Although the VDR is present and ligand-activated in all cell
types, the genomic impact of the VDR appeared to be greatest
in undifferentiated MSCs.
GREAT association of VDR genomic ChIP-seq peaks with
neighboring genes resulted in 9,599 peaks being associatedwith
7,167 genes. This highlights the likelihood that many genes
havemultiple peaks of VDR/RXRbinding, aswas demonstrated
for PPAR, RUNX2, C/EBP, and C/EBP binding in Fig. 3E.
There is a higher correlation with ChIP-seq peaks (76%) and
genes that are up-regulated by 1,25(OH)2D3. The most
enriched GO term categories for the up- and down-regulated
genes are shown in the right panel of Fig. 4E. According to these
enriched categories, 1,25(OH)2D3-mediated gene expression
does not favor osteoblast-specific categories. Finally, ChIP-seq
data tracks are presented for three genes thatwere up-regulated
by gene expression in each of the differentiation states: MyoD
family inhibitor (Mdfi) (Fig. 4F), proline-rich Gla protein 4
(Prrg4) (Fig. 4G), and glycerophosphodiester phosphodiester-
ase domain-containing 5 (Gdpd5) (Fig. 4H). The overlaid ChIP-
seq data tracks for VDR in the vehicle (Veh, yellow) and
1,25(OH)2D3 (1,25D3, blue) conditions (where overlapping
tracks appear green) are displayed for each of the differentiation
states of theMSCs as well as for RXR inMSCs only for compar-
ison. There was a strong enrichment of VDR following treat-
ment with 1,25(OH)2D3, as indicated in the ChIP-seq data hub
tracks. Whereas Mdfi and Prrg4 loci display single peaks of
VDR/RXR binding activity at 8 and 15 kb, respectively, it
appears as though the Gdpd5 locus contains several peaks of
VDR/RXR binding activity that may comprise enhancers for
the control of expression of this gene. This latter model was
found to be important in the regulation of many vitamin D-re-
sponsive genes, such asMmp13,Vdr, c-Fos,Tnfsf11,Trpv6, and
others (15, 43, 47, 50–53).
Epigenetic Transitions Predict Crucial Regulatory Loci during
Differentiation—Transcription factors bind to the genome in a
punctate pattern and are vital mediators of external cellular
stimuli. These events can be preceded by, or are an effect of, the
chromatin landscape in which they reside; therefore, histone
modifications can be accurate predictors of the genomic tran-
sitions (26).We investigated five different chromatinmodifica-
tion marks that specify important genomic locations, such as
transcriptional start sites (H3K4me3) or enhancer signatures
(H3K4me1), or genomic events such as transcriptional elonga-
tion (H3K36me3) or gene activation (H4K5ac and H3K9ac)
(26). In Fig. 5A, ChIP-seq peaks are tabulated for these chroma-
tin modification marks in the absence or presence of
1,25(OH)2D3 for each differentiation state. From a cis-regula-
tory element annotation system (CEAS) analysis in Fig. 5B, we
found that these histone marks followed the expected genomic
distribution profiles when all gene bodies throughout the
genome are averaged together to display the ChIP-seq tag den-
sities as reported previously (54). During differentiation, peaks
shifted in amplitude (greater or lesser peak reads) but not nec-
essarily in location, similar to recent observations (55). Thiswas
demonstrated in Fig. 5C, where the peak overlap of the H3K9ac
mark inMSCs versusMSC-B7 cells, as one example, represents
99 and 92% of all peak locations, respectively. This was in con-
trast to the H3K9ac mark, where 76 and 87% of peaks were
found to overlap following differentiation of MSCs into
MSC-F7 cells, leaving 7,543 sites unique to MSCs and 2,760
sites unique to MSC-F7 cells. These relationships were
observed in the remaining histone modification marks as well
(ChIP-seq raw reads). Therefore, MSC-B7 cells exhibited an
epigenetic profile that is similar to that of undifferentiated
MSCs, whereas the profile for MSC-F7 cells is dramatically
different.
Accompanying changes in the transcriptome, therewere also
differences in the amplitude of the epigeneticmarkswhen com-
paringMSCswith eitherMSC-F7 cells orMSC-B7 cells, as seen
in Fig. 5D. Here, TSSs were averaged across the genome (from
3 to3 kb) using the CEAS analysis tool and compared using
ChIP-seq tag densities, shown as “average profile.” Averaged
H3K9ac data that span the TSSs of all genes appear as a black
line and display a typical H3K9ac profile that is enriched before
and immediately after the TSS (valley of activity directly over
the TSS). However, an examination of the TSS region from
genes that are regulated during differentiation into MSC-B7
cells (up-regulated, blue; down-regulated, yellow) and MSC-F7
cells (up-regulated, green; down-regulated, dark green) revealed
specific enrichments of the H3K9ac mark at genes regulated in
MSC-B7 compared with MSC-F7 cells (left). For genes regu-
lated in MSC-F7 cells (right), H3K9ac enrichment was much
greater than that seen in MSC-B7 cells. These genome-wide
observations are best illustrated at the gene level at two loci that
surround the Adipoq (adiponectin) (Fig. 5E) and Lipe (hor-
mone-sensitive lipase) genes (Fig. 5F), which are highly and
specifically up-regulated in MSC-F7 cells. ChIP-seq data over-
laid track hubs for each differentiation state (MSC (pink),
MSC-B7 (blue), MSC-B15 (yellow), and MSC-F7 (green)) for
H3K9ac, H4K5ac, H3K4me1, H3K4me3, and H3K36me3
revealed an increase in each histone mark specifically in
MSC-F7 cells (enrichment of green). Although enrichment at
the Adipoq locus was highly punctate for H4K5ac and
H3K4me1 directly upstream of the TSS, overlapping PPAR
and C/EBP binding sites, these histone marks were more
broadly distributed across the Lipe gene locus.
Histone modifications are also predictive of activated loci
after treatment with 1,25(OH)2D3. In Fig. 5G, CEAS-averaged
TSS analysis was applied to genes that were up- or down-regu-
lated by 1,25(OH)2D3 treatment. Genes that were activated or
up-regulated (red) by 1,25(OH)2D3 exhibited enrichments for
both H3K9ac (left) and H3K4me3 (right) that were specific for
1,25(OH)2D3 (solid red line). Genes that were down-regulated
(gold lines; 1,25(OH)2D3 (solid) and vehicle (dashed)) showed
no enrichment for these histone modifications, which are typ-
ically associated with active chromatin. These data are high-
lighted through the ChIP-seq overlaid data tracks visualized in
Fig. 5H. The histone marks H3K9ac and H3K4me3 are dis-
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FIGURE 5. Epigenetic transitions predict crucial regulatory loci during differentiation. A, ChIP-seq peak numbers of histone modification markers H4K5ac,
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played near the Mdfi gene, which was recently profiled for its
transcription factor binding (15). Mdfi is shown to contain
potential enhancers near the TSS and upstream at8 kb and is
up-regulated by 1,25(OH)2D3 in virtually all of the differentia-
tion states examined (MSC, 11-fold; MSC-B7, 13-fold; MSB-
B15, 4.5-fold; MSC-F7, 12-fold; supplemental Table 1). The
ChIP-seq data hub tracks, which contrast cells treated with
either vehicle or 1,25(OH)2D3, reveal 1,25(OH)2D3-induced
enrichment of H3K9ac (blue) at the 8 kb region in all differ-
entiation states. H3K4me3was selectively enriched only imme-
diately downstream of the Mdfi TSS. Therefore, undifferenti-
ated MSCs exhibit an epigenetic signature that resembles that
seen in MSC-B7 cells, and histone modifications appear to be
predictive of activated gene loci following both differentiation
and hormone-induced treatments.
Epigenetic Patterns in MSCs Predict Lineage Preference for
Osteoblastic Differentiation—There is growing evidence for an
epigenetic preference that favors the differentiation ofmarrow-
derived MSCs toward the osteoblast lineage in genes that are
up-regulated by osteogenic differentiation. This stands in stark
contrast to genes in MSCs that are selectively up-regulated fol-
lowing adipogenic differentiation. An excellent example of this
contrast can be seen at the gene locus that encodes osteopontin
(OPN, Spp1) in Fig. 6A as compared with the gene locus for
Cebpa in Fig. 6B. ChIP-seq data hub tracks are presented for
RXR, C/EBP, RUNX2, C/EBP, PPAR, H3K9ac, H4K5ac,
H3K4me1, H3K4me3, and H3K36me3 (top) in each differenti-
ation state (MSC (pink), MSC-B7 (blue), MSC-B15 (yellow),
and MSC-F7 (green)) as well as VDR and RXR (bottom) in the
absence or presence of 1,25(OH)2D3. Spp1 is up-regulated
following osteogenic differentiation (2–4-fold) and by 1,25
(OH)2D3 (4-fold) yet down-regulated during adipogenic differ-
entiation (2-fold). The Spp1 genomic locus retains several puta-
tive enhancers located upstreamof theTSS that are occupied by
VDR/RXR, RUNX2, and C/EBP, as documented previously
(15). The Spp1 gene is expressed in a wide variety of cell types,
however, and may also manifest components responsible for
cell type-selective expression. Thus, the more proximal
enhancers contained ligand-activated VDR/RXR recruitment
and histone modifications that remain unchanged relative to
undifferentiated MSCs. However, enhancers at the 27 and
43 kb regions are also seen to bind additional transcription
factors that include C/EBP and RUNX2 as well as PPAR and
C/EBP. At these sites, the histone profiles for H3K9ac,
H4K5ac, and H3K4me1 are unexpectedly more robust in
MSC-F7 cells as compared withMSCs (green increased). The
separation of these epigenetic marks to more proximal or
more distal regions may provide distinct mechanisms of up-
regulation (proximal) and down-regulation (distal) at the
Spp1 gene in different cell types. The locus near the Cebpa
gene, on the other hand, which is up-regulated in MSC-F7
cells3-fold compared with its down-regulation inMSC-B7
cells (4-fold down-regulation) and MSC-B15 cells (11-fold
down-regulation), is dominated by an increase in histone
marks in MSC-F7 cells (green) and an increase in PPAR at
sites downstream of Cebpa. There is also a ligand-dependent
binding of VDR/RXR downstream of Cebpa, despite the fact
that Cebpa does not appear to be statistically up- or down-
regulated by 1,25(OH)2D3 in any of these differentiated cell
types (supplemental Table 1). We are therefore able to use
chromatin signature marks similar to those found near Spp1
and Cebpa to accurately predict important genomic loci that
might be essential for differentiation.
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Transcriptomic and Epigenetic Plasticity in Trans-differenti-
ated Cells—Following the genome-wide observation that MSC
and MSC-B7 epigenetic profiles are similar, whereas MSC to
MSC-F7 profiles exhibitmore dramatic differences, we hypoth-
esized that adipogenic differentiation might represent a more
committed terminal state of differentiation than that seen in
the osteoblast, a subset of which are known to differentiate
further into bone lining cells or osteocytes. To investigate this
hypothesis, we conducted a series of trans-differentiation
experiments wherein cells were grown in osteogenic (OM), adi-
pogenic (AM), or standard growth medium lacking any added
compounds (Basal) (Fig. 7) for 3 days and then cultured for an
additional 7 days in medium that induced the alternative state
of differentiation. We then stained the cells with either AR or
ORO, isolated RNA for qPCR gene expression analysis, and
subjected the cells to ChIP-qPCR analysis at days 0, 3, and 10, as
summarized in Fig. 7A. As documented in Fig. 7B, we found
that after 3 days in osteogenicmedium, AR staining revealed, as
expected, an extensive calcium deposition that resulted in
dense bone nodules after 10 days in culture. When transferred
to adipogenic medium, however, the cells began to form lipid
droplets, as assessed by ORO staining as seen in Fig. 7B (right),
indicating a change in morphology toward adipogenic cells.
ORO staining was positive only in cells that had been exposed
to the adipogenic medium and was highly efficient. In contrast,
cells exposed to adipogenic medium (Fig. 7B) displayed lipid
droplet formation and positive staining for ORO both at 3 days
and at 10 days. However, adipogenic cells that were transferred
back to basal (control) medium displayed a reduction in lipid
droplet formation, whereas this stain was absent in the adipo-
genic cells that were transferred into osteogenic medium for 7
days. Indeed, the latter cells began to form dense bone mineral
nodules and stained positive for AR.
To confirm potential transcriptomic signatures, RT-qPCR
was performed on samples acquired at 0, 3, and 10 days for
genes relevant to osteogenic biology (Spp1, Mmp13, and
Runx2) as well as those important for adipogenic identity
(Cebpb, Pparg, Adipoq, Cebpa, and Lipe), displayed in Fig. 7C.
Spp1 expression was increased 3-fold in control medium (tan
bounding box) after 3 days (first tan bar), unchanged after an
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FIGURE7.Cellular trans-differentiationwasaccompaniedbymorphological and transcriptomic changes.A, experimental design andoverview.Marrow-
derived cells were isolated, and MSCs were preserved through culturing. MSCs were then differentiated in osteogenic (OM) or adipogenic medium (AM) for 3
days. At this time, the cellswere then switched to the opposingdifferentiationmixture for an additional 7 days (10 days total). Gene expression, ChIP assay, and
staining were performed at days 0, 3, and 10. B, differentiated cells were stained with AR (left) and with ORO (right). All images were at 4magnification. C,
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Epigenetic Plasticity MaintainsMSCDifferentiation
17840 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 34•AUGUST 19, 2016
additional 7 days (second tan bar) in control medium, and fur-
ther increased in osteogenic medium (black bar). The transi-
tion into adipogenic medium decreased Spp1 expression 4-fold
(first tan bar versus green bar). In cells initially exposed to osteo-
genic medium (gray bounding box), Spp1 was elevated in
response to a change to basalmediumand elevated even further
when subjected to osteogenic medium for a further 10 days. As
with basal medium, the further exposure of osteogenic cells to
adipogenic medium resulted in a strong repression of Spp1.
Finally, Spp1 expression in adipogenic cells was only slightly
elevated when the cells were further exposed to either basal or
osteogenic medium for additional periods of time. Continual
adipogenicmediumexposure resulted in sustained suppression
of Spp1 at 3 and 10 days. These relationshipswere also observed
for theMmp13 andRunx2 genes. Expression profiles forCebpb,
Pparg,Adipoq,Cebpa, and Lipewere dependent upon the pres-
ence of adipogenic medium and signaling and were increased
regardless of when the adipogenic medium was applied.
In a final study, we utilized ChIP-qPCR analysis to evaluate
the effects of trans-differentiation on key histone modifica-
tions. The experimental design and display were identical to
those seen in Fig. 7C. Cells were subjected to a ChIP assay at
days 0, 3, and 10 and immunoprecipitated with antibodies to
H3K9ac, H4K5ac, H3K4me1, H3K4me3, and H3K36me3 as
well as with a nonspecific IgG control. As seen in Fig. 8A, the
ChIP-qPCR primers used were located near the Spp1 TSS
(200/100 bp), and the data displayed represent ChIP analy-
sis for H3K9ac (top) and IgG control (bottom) at this site. The
ChIP-qPCR results seen in Fig. 8A mirror the results of Spp1
gene expression seen in Fig. 7C. H3K9ac levels remained
unchanged in cells that were treated with either basal (tan
bounding box) or osteogenic (gray bounding box) medium for
3–10 days. Cells cultured in adipogenic medium (green bound-
ing box), however, displayed a 4–5-fold decrease in histone
acetylation, indicating a loss of transcriptional activity. The
nonspecific IgG immunoprecipitation data demonstrate that
these activities were specific because they remained unchanged
during treatment conditions and were significantly lower than
all immunoprecipitation samples. The IgG for the remaining
regions was as low or lower than the data displayed for Spp1;
therefore, this was omitted from the figure for clarity. In Fig. 8B,
ChIP-qPCR analysis of marks for both H3K9ac and H3K4me3
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FIGURE 8. Trans-differentiation was assisted by genomic plasticity in histonemodificationmarkers. ChIP-qPCR was performed on the cells throughout
differentiation at the indicated time points for H3K9ac, H4K5ac, H3K4me1, H3K4me3, and H3K36me3. MSCs without differentiation (D0, blue) are compared
with cells cultured for 3 days in basal medium (Basal 3D, tan bounding box and first tan bar), osteogenicmedium (OM 3D, gray bounding box and first gray bar),
or adipogenic medium (AM 3D, green bounding box and first green bar). Cells were then differentiated for an additional 7 days as indicated with basal medium
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was also performed using primers located near a region 500
bpdownstreamof theLipe geneTSS.As seen in Fig. 8B, the data
derived from this analysis also mirrored that seen for the
expression of the Lipe gene in Fig. 7C. Histone marks were
increased only in cells cultured in adipogenic medium, and
these marks were increased even after mineral matrix began to
form (OM3D). Histonemarks at the loci for theCebpa (2 kb)
and Adipoq (TSS 0.5 kb and 11 kb) genes were also
increased when adipogenic medium was applied regardless of
the differentiation state. Taken together, the flexibility or plas-
ticity of the epigenetic profiles enables MSCs to respond to
alternative stimuli rather than to commit to a terminal differ-
entiation process. Thus, MSCs are able to display cellular char-
acteristics appropriate to mature mineralizing osteoblasts even
after displaying adipogenic features that include the formation
of ORO-positive lipid droplets.
Discussion
Recent investigations into the differentiation of the osteo-
blast have revealed the presence of an intricate relationship
between the transcription factors RUNX2, C/EBP, and VDR/
RXR that is formed around genes important for osteoblast
function and differentiation (15, 16). These studies were ini-
tially performed in the MC3T3-E1 cell model system in which
the transition of preosteoblasts intomaturemineralizing osteo-
blast cells was investigated. Similarly, there have been several
studies utilizing the preadipocyte cell line 3T3-L1 to explore
adipocyte differentiation with PPAR, C/EBP, and numerous
additional transcription factors, including the VDR, as targets
(22, 56, 57). The current model system of marrow-derived
MSCs presented herein displays distinct advantages over both
the MC3T3-E1 and the 3T3-L1 cell models. First, the multipo-
tential nature of the MSCs allows an investigation of cellular
transition into several different cell types using the same start-
ing material. Second, marrow-derived MSCs can be isolated
from transgenic or knock-out animalmodels, permitting inves-
tigations of the contributions of the genetic manipulations to
the growth and differentiation of the cells (34). Finally, due to
their accessibility from patients, the differentiation and repro-
gramming ofMSCs ex vivo have become a focus in clinical ther-
apeutics and drug discovery. For these reasons, we sought a
thorough investigation of the mechanisms of gene activation,
expression, genome binding, and epigenetic transitions in the
differentiating MSCs and to provide a dense archive of ChIP-
seq andRNA-seq that can be further deciphered by the research
community because data on bone tissues are absent or limited
from ENCODE data sets.
As we observed previously in theMC3T3-E1 cells (16) and as
evidenced from the 3T3-L1 literature (22, 56, 57), transcription
factors essential for osteogenic (RUNX2 and C/EBP) and/or
adipogenic (PPAR and C/EBP) differentiation appear poised
or are already present at many locations through the genome in
undifferentiated MSCs regardless of their origin. During the
process of differentiation, these factors either increase/de-
crease in abundance at specific enhancers or, with less fre-
quency, bind at de novo sites. The peak overlap table (Table 1)
demonstrates that although there are unique peaks of activity
for each differentiation state, the majority of transcription fac-
tors are bound to the same enhancer locations, and if changes
do occur, they are largely of amplitude. Examples of this behav-
ior were apparent at the Adipoq gene locus seen in Fig. 3D. At
this gene, however, PPAR and RXR binding both increased
from an existing residual level at specific sites (adjacent to the
TSS and3 kb) and occupied additional de novo sites (1 kb)
following MSC-F7 differentiation (green). We also found that
many additional factors bound to the3 kb enhancer upstream
ofAdipoq. Binding sites for factors such as VDR, RXR, C/EBP,
andC/EBP did not change in response toMSCdifferentiation,
and all cell differentiation states were equally overlapping. Sim-
ilar observations were made at theMmp13 (Fig. 3D), Spp1 (Fig.
6A), and Cebpa (Fig. 6B) loci. Further studies using ChIP-re-
ChIP, where ChIP is performed for one factor, followed by a
second immunoprecipitation for a co-bound factor, would help
reveal which of these factors are present at the same time and
physically interacting on the same piece of DNA to further our
understanding of themechanism (58). However, it is important
to remember that these factors may not be directly related to
activity of genes in the same genomic vicinity. Interactions of
chromatin modifiers (readers and writers for the histone
marks) and other coactivators also operate during the activa-
tion. Perhaps other transcription factors and/or co-repressor
presence are necessary for repression. Nonetheless, the pres-
ence and location of these essential factors provide the first
level of mechanistic understanding, and their activities high-
light the complexity of regulation and the potential coordina-
tion of several transcription factors that are frequently observed
at thousands of locations throughout the genome.
Ligand activation of the VDR, a secondary activator and
signal-dependent factor, and genomic binding with its RXR
partner create a different gene activation dynamic in differen-
tiated cells compared with parental MSCs. Although the
genomic footprint of ligand-activated VDR is dramatically
reduced (from 10,557 to 823 (MSC-B7), 1,365 (MSC-B15), and
616 (MSC-F7)), 1,25(OH)2D3-activated VDR is able to regulate
similar numbers of genes in each cell type. These findings are
consistent with data generated in the MC3T3-E1 cell line (15,
16) when these preosteoblast precursor cells were differenti-
ated into mature osteoblastic mineralizing cells in osteogenic
medium. The gene networks activated by 1,25(OH)2D3 in each
differentiated cell type derived from the MSCs were distinct,
with only 11 genes being up-regulated and one gene (Ibsp)
down-regulated in common in each differentiation state.
Finally, examination of the most common or overrepresented
sequences in these peaks revealed that a typical VDRE was
found to be the most abundant sequence located in 20–35% of
the total peaks, which lends credence to the fidelity of this data
set. These analyses, however, should not be misinterpreted to
suggest that aVDREwas not found in the remaining 80–65%of
the ChIP-seq peaks. A position weight matrix-based search
found that 90% of all ChIP-seq peak sequences contained a
DR3 typeVDREnear the peakmaxima or pairs of VDREs flank-
ing the apparent peak center. These data are consistent with
our previous conclusions regarding VDR cistromes in human
LS180 colonic cells, mouse IDG-SW3 osteocytic cells, and
mouse MC3T3-E1 osteoblastic cells (15, 47, 59). Interestingly,
these regions are also enriched in sequences for AP1/Jun,
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RUNX2, and C/EBP motifs in the osteogenic differentiated
cells (15). However, in the MSC-F7, sequence motifs for the
transcription factors NKX2–5 (NK2 homeobox 5) and IRF5/6
(interferon regulatory factor 5 and 6) motifs were present. The
NKX2–5 protein is involved in heart development (60). IRF5/6
transcription factors are involved in inflammatory pathway sig-
nal transduction (61). Despite the overrepresentation of these
motifs in our data sets, each pathway will require extensive
investigation to determine their contribution to VDR hormone
signaling in adipocytes.
From a broad level of expression, epigenetic changes were a
predictor of the important gene loci for differentiation. These
histone marks result from the recruitment and activity of his-
tone-modifying enzymes, such as histone acetyl- and methyl-
transferases, that are the readers andwriters of the genome (62,
63). Detailed CEAS analysis of ChIP-seq enrichment near gene
TSSs correlated well with genes that were regulated. The epi-
genetic profiles for MSC-B7 (7 days in osteogenic medium)
were nearly indistinguishable from those seen in undifferenti-
atedMSCs at genes that were up-regulated following osteoblast
differentiation, includingMmp13 and Spp1, andnear theDmp1
(115-fold increase inMSC-B7 versusMSC) locus (ChIP-seq raw
data). This was in contrast to observations made following adi-
pogenic differentiation, where histone marks were specifically
enriched around adipogenic genes, such asAdipoq, Lipe,Cidec,
Cebpa,Fabp4,Klf15,Plin1,Pparg, Setd8, andmany others (sup-
plemental Table 1 and ChIP-seq raw data). In these studies, we
focused on the process of activation in response to differentia-
tion. Each histone mark provided insight into different aspects
of chromatin regulation, such that ChIP-seq analysis of candi-
date transcription factors may not be necessary initially to
understand the importance of the gene locus for differentiation.
TheH3K9ac andH4K5acmarks associatedwith active enhanc-
ers were duplicative in nature (activation); however, each mark
revealed unique profiles. At theAdipoq gene locus, the H3K9ac
mark exhibited its highest enrichment near the TSS coinciding
with H3K4me3, whereas H4K5ac, while enriched at the TSS,
was also increased at the upstream enhancers that also coin-
cided with the H3K4me1 mark. Coupled with our factor occu-
pancy data, it is clear that these regions are important for
PPAR and C/EBP binding. Nevertheless, the importance of
this region as an enhancer is implied even in the absence of
these types of data. The dynamics of acetylation profiles (e.g. the
punctate patterns at the Adipoq and Cebpa genes versus the
broad histone profiles at the Lipe gene) facilitate the categori-
zation of gene activities across the genome and create a hierar-
chy of genes involved in differentiation. It is possible that a
diverse set of multiple enhancers and broad active chromatin
may indicate a wider portfolio of responses to cellular stimuli
and differentiation. The reverse of these activation marks are
those that are involved in repression (H3K27me3) and silencing
(H3K9me3). Although we did not examine repressive marks in
these studies, their involvement would further illuminate the
patterns necessary for the multipotential nature of the MSCs.
We believe that the activation dynamics identified in this
study enhance an already attractive cell model system in which
to study the epigenetic plasticity of MSC regulation. Whereas
there is strong evidence for trans-differentiation of cells in vivo
(30–33), we also sought to define this process in response to the
adipogenic or osteoblastic signaling growth mixtures at a
mechanistic level. The environment, in our case the differenti-
ationmixture, determined the phenotypic outcome, epigenetic
restructuring, and therefore function analogous to macro-
phages that are deposited in different tissues and appear to
acquire unique genetic and epigenetic features from their envi-
ronment that determine their specific functions (64). This con-
cept could be applicable toMSCs relative to their tissue origins.
The epigenetically preprogrammed pathway for marrow-de-
rivedMSCs appears to be osteogenic; however, the potential for
adipocyte differentiation remains intact, despite expression of
the reported adipocyte defying Grem1 in the MSCs and
MSC-B7 cells (40). This differentiation potential is highlighted
in the pathology associated with skeletal fragility, including
increasedmarrow adiposity due to less physical exertion, aging,
and estrogen deficiency (65–67). The marrow microenviron-
ment and resulting MSCs may react and respond to the
increased adiposity, causing an increase in the propensity for
MSCs to become adipose or even for existing osteogenic cells to
be trans-differentiated into fat. This in turn results in a cascade
of signaling pathways being activated and changes in the
expression and elaboration of Wnts/-catenin, bone morpho-
genic proteins, and other growth factors that are capable of
driving cells toward a clinically undesired outcome (68–70).
Our original hypothesis that the adipogenic cells might be
terminally and irreversibly committed appeared to be inaccu-
rate because we were successful in transitioning adipocytes
back into mineral matrix-depositing osteoblast-like cells. The
cell morphology and staining patterns in these trans-differen-
tiated cells were consistent with individual osteoblast versus
adipocyte phenotypes. These transitions did not occur ran-
domly, however, because differentiation was uniform across
the plates, and the gene expression profiles were unequivocal
for the appropriate cell type. For example, there were no linger-
ing remnants of osteoblast expression in adipocyte trans-differ-
entiated cells. The most interesting results found during the
trans-differentiation processwere in relationship to the profiles
of histone marks. Despite examining these transitions with
ChIP-qPCR rather than ChIP-seq analysis, we still found that
epigenetic profiles mirrored the gene expression results at
many locations (guided by the ChIP-seq for primer design).
Because there was high expression of Adipoq in cells with an
adipogenic medium mixture, the histone modifications
decreased after the adipogenic signals were removed. In fact,
this was true for all genes up-regulated by adipogenesis (Pparg,
Cebpa, Lipe, and others (ChIP-seq raw data)), thereby demon-
strating that epigenetic plasticity is required for these transi-
tions. Importantly, these patterns of the transitioningMSCmay
contain unique epigenetic signatures that are dependent upon
cellular origin (adipose, osteogenic, or chondrogenic), disease
status (healthy or tumorigenic), or even their final site of local-
ization (bone matrix, fat pad, or brain).
The identification of histone marks and accompanying sig-
nals, whether in vitro or in vivo, is vital to understanding gene
regulation in a broader context. Genome-wide association
studies undertake the difficult task of identifying regions of the
genome, and more precisely SNPs, that have a higher correla-
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tion with certain disease risk groups. A majority of the SNPs
that have been identified occur in the vastness of the non-cod-
ing portions of the genome (71). These SNPs can act as genomic
beacons to highlight crucial enhancers, regulators, or structure
for gene regulation and disease progression. Many enhancers
may be connected through intergenic (or interchromosomal)
loops, whereby SNPsmay have far reaching, difficult-to-predict
effects on gene expression. Our recent data utilizing CRISPR
(clustered regularly interspaced short palindromic repeats) in
the Mmp13 gene locus showed that disruption of the 30 kb
RUNX2-bound enhancer was responsible for the altered bind-
ing activity of several additional transcription factors at the
remaining distal enhancers and ultimately inactivation of tran-
scription of the gene itself (43, 72). The presence of SNPs in
regions that contain histone marks may be important in deter-
mining their specific functions and may help to determine
mechanisms and perhaps guide therapeutic intervention.
In conclusion, the multipotential nature of MSCs creates a
desirable model in which to study the formation of many dif-
ferent tissue types. We found that transcription factors
required for each differentiation state were present in the
undifferentiated MSCs and were poised for regulation. These
genetic responses were the cause of, or reaction to, the epige-
netic changes that drive the cellular transitions. The epigenetic
profiles of the marrow-derived MSC closely resemble the
osteogenic differentiated cells and indicate a default bone fate.
The plasticity of these epigenetic marks allows the MSC to
maintain its multipotential role and provide precursors for the
various differentiated cell types as needed.
Experimental Procedures
Reagents—1,25(OH)2D3 was obtained from SAFC Global
(Madison, WI). ChIP antibodies to VDR (C-20, sc-1008, lot
G2511), RXR (	N-197, sc-774, lot G2310), C/EBP (C-19,
sc-150, lot F3011), and C/EBP (14AA, sc-61, lot J1811) were
purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX).
Antibodies to PPAR (81B8, 2443s, lot 2) were purchased from
Cell Signaling Technology (Danvers, MA). Antibodies to
H4K5ac (07-327, lot DAM1794310) and H3K9ac (06-942, lot
31636) were purchased from Millipore (Billerica, MA). Anti-
bodies for H3K4me1 (ab8895, lot GR43807-1), H3K4me3
(ab1012, lot GR10853-1), and H3K36me3 (ab9050, lot
GR52625-1) were purchased from Abcam (Cambridge, MA).
All quantitative real-time PCR (qPCR) reagents (Fast Start
SYBR Green Master Mix (w/rox)) were obtained from Roche
Applied Science, and TaqMan gene expression assays were
from Life Technologies (Applied Biosystems, Foster City, CA).
All qPCR was conducted on a StepOnePlus system from
Applied Biosystems. Primers were obtained from IDT (Cor-
alville, IA), and the sequences are available in supplemental
Table 1.
Cell Culture and Differentiation—Marrow-derived MSCs
were isolated from female C57bl/6 mice, cryopreserved, and
expanded through no more than 10 passages (34, 35). The
MSCs were cultured in minimum Eagle’s medium modifica-
tion supplemented with 10% fetal bovine serum from Hyclone
(Logan, UT) and 1% penicillin-streptomycin from Invitrogen.
For differentiation, cells were grown to confluence and then
transferred to either osteogenic differentiationmedium (10mM
-glycerophosphate and 50 g/ml ascorbic acid) or adipogenic
differentiation medium (5 g/ml insulin, 50 M indomethacin,
0.1 M dexamethasone) for the indicated periods, which was
replenished every 2–3 days until the assay. Cells were stained
with AR as reported previously (4). In addition, cells were also
stained with ORO to detect the presence of lipids. Briefly, the
cells werewashed in PBS, fixedwith 10% formaldehyde solution
for 30 min at room temperature, incubated with 100% propyl-
ene glycol (Poly Scientific, Bay Shore, NY) for 5 min at room
temperature, stained with 0.5% ORO solution (Poly Scientific)
for 10min at 60 °C, treated with 80% propylene glycol for 5min
at room temperature, washed with double-distilled H2O, and
dried. All AR and ORO samples were imaged with a 4
objective.
Gene Expression Analysis—Cells were treated for 24 h with
ethanol vehicle or 100 nM 1,25(OH)2D3, and 1 g of isolated
total RNA was reverse transcribed using the High Capacity
cDNA kit (Applied Biosystems) and then diluted to 100l with
RNase/DNase-free water. qPCR was performed using primers
specific for a select set of genes by TaqMan analyses as indi-
cated and listed in supplemental Table 1.
ChIP Followed by Sequencing (ChIP-seq)—Chromatin immu-
noprecipitation was performed as described previously (47).
Briefly, cells (both pre- and post-differentiation) were treated
for 3 hwith vehicle or 100 nM 1,25(OH)2D3 after differentiation
as reported previously (50). Samples were subjected to immu-
noprecipitation using either a control IgG antibody or the indi-
cated experimental antibody (15, 16). All ChIP and ChIP-seq
methodology, including statistical information and data pro-
cessing, were performed as reported recently (16).
RNASequencing—RNA-seqwas performed as described pre-
viously (59, 73). MSCs were differentiated and treated for 24 h
with vehicle or 100 nM 1,25(OH)2D3 before RNA was isolated
using the TRI-Reagent protocol (MRC, Cincinnati, OH). Eight
micrograms of total RNA were DNase I-treated (Invitrogen)
and then ribosome-depleted using the RiboMinus eukaryote kit
(Invitrogen) according to the manufacturer’s instructions.
Directional RNA-seq libraries were prepared with the Epicen-
ter (Madison, WI) ScriptSeq version 2 RNA-seq library prepa-
ration kit as per the manufacturer’s instructions. Ribosomal
RNA depletion (RNA 6000 Nano Kit) and final library quality
(high sensitivityDNAkit) were quality-controlled using anAgi-
lent Bioanalyzer (Agilent, Santa Clara, CA).
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